Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Medtronic initially won FDA approval in August for its next-generation Simplera CGM. The Simplera platform includes the ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S ...

DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the longest-lasting and most accurate CGM approved in the United States.

G7 15 Day Continuous Glucose Monitoring (CGM) System received FDA clearance for use in adults with diabetes. The new device, which is the longest-lasting and most accurate CGM system according to the ...

not previously used for monitoring, that had been programmed with RSP Systems' algorithm RSP's device also enabled the reduction in the pre-calibration period from several weeks to c.4 hours Study ...